Corvus Pharmaceuticals Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
© -
My name is Evan Seigerman. As many of you know, I'm the senior large cap biotechnology analyst here at Crédit Suisse and it's my pleasure to introduce Corvus. And from Corvus, we have the Chief Medical Officer, Dr. Mehrdad Mobasher.
Thank you for the introduction. Thanks for having us here and being here, those who are on the line. So we'll get started and apologies for the little delay that we had.
This is our forward-looking statement. It's public. I'm not going to spend any time on it. I just thought I will spend a minute and introduce our team. Dr. Richard Miller is our CEO. He is a hematologist-oncologist. And you can see that himself and the list of our -- my other colleagues at Corvus, they have all been key in development of some of the new novel treatments in hematology and oncology. And my colleague Leiv is here. He is our CFO and will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |